Amoxicillin for
PreclinicalSmall molecule
GSKAmoxicillin for is one of 11 small molecule programs targeting Otitis media. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
10
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Otitis Media
#DrugCompanyPhaseTrials
1Cipro
BayerApproved
Biaxin
AbbVieApproved
Keflex
Eli LillyApproved
Levaquin
WWim Janssens
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Decadron
AAspen Global Incorporated
Approved
Acetadote
AArbor Pharmaceuticals, Inc.
Preclinical
Xylometazoline
NovartisPreclinical
Sulfamethoxazole-Trimethoprim
NNational Institute of Allergy and Infectious Diseases (NIAID)
Preclinical
Augmentin
TevaPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Amoxicillin for. EMBL-EBI & Wellcome Sanger Institute.
- [4]